BACKGROUND: IL-17A has been implicated in severe forms of asthma. However, the factors that promote IL-17A production during the pathogenesis of severe asthma remain undefined. Diesel exhaust particles (DEPs) are a major component of traffic-related air pollution and are implicated in asthma pathogenesis and exacerbation. OBJECTIVE: We sought to determine the mechanism by which DEP exposure affects asthma severity using human and mouse studies. METHODS: BALB/c mice were challenged with DEPs with or without house dust mite (HDM) extract. Airway inflammation and function, bronchoalveolar lavage fluid cytokine levels, and flow cytometry of lung T cells were assessed. The effect of DEP exposure on the frequency of asthma symptoms and serum cytokine levels was determined in children with allergic asthma. RESULTS: In mice exposure to DEPs alone did not induce asthma. DEP and HDM coexposure markedly enhanced airway hyperresponsiveness compared with HDM exposure alone and generated a mixed T(H)2 and T(H)17 response, including IL-13(+)IL-17A(+) double-producing T cells. IL-17A neutralization prevented DEP-induced exacerbation of airway hyperresponsiveness. Among 235 high DEP-exposed children with allergic asthma, 32.2% had more frequent asthma symptoms over a 12-month period compared with only 14.2% in the low DEP-exposed group (P = .002). Additionally, high DEP-exposed children with allergic asthma had nearly 6 times higher serum IL-17A levels compared with low DEP-exposed children. CONCLUSIONS: Expansion of T(H)17 cells contributes to DEP-mediated exacerbation of allergic asthma. Neutralization of IL-17A might be a useful potential therapeutic strategy to counteract the asthma-promoting effects of traffic-related air pollution, especially in highly exposed patients with severe allergic asthma.
BACKGROUND:IL-17A has been implicated in severe forms of asthma. However, the factors that promote IL-17A production during the pathogenesis of severe asthma remain undefined. Diesel exhaust particles (DEPs) are a major component of traffic-related air pollution and are implicated in asthma pathogenesis and exacerbation. OBJECTIVE: We sought to determine the mechanism by which DEP exposure affects asthma severity using human and mouse studies. METHODS: BALB/c mice were challenged with DEPs with or without house dust mite (HDM) extract. Airway inflammation and function, bronchoalveolar lavage fluid cytokine levels, and flow cytometry of lung T cells were assessed. The effect of DEP exposure on the frequency of asthma symptoms and serum cytokine levels was determined in children with allergic asthma. RESULTS: In mice exposure to DEPs alone did not induce asthma. DEP and HDM coexposure markedly enhanced airway hyperresponsiveness compared with HDM exposure alone and generated a mixed T(H)2 and T(H)17 response, including IL-13(+)IL-17A(+) double-producing T cells. IL-17A neutralization prevented DEP-induced exacerbation of airway hyperresponsiveness. Among 235 high DEP-exposed children with allergic asthma, 32.2% had more frequent asthma symptoms over a 12-month period compared with only 14.2% in the low DEP-exposed group (P = .002). Additionally, high DEP-exposed children with allergic asthma had nearly 6 times higher serum IL-17A levels compared with low DEP-exposed children. CONCLUSIONS: Expansion of T(H)17 cells contributes to DEP-mediated exacerbation of allergic asthma. Neutralization of IL-17A might be a useful potential therapeutic strategy to counteract the asthma-promoting effects of traffic-related air pollution, especially in highly exposed patients with severe allergic asthma.
Authors: Yui-Hsi Wang; Kui Shin Voo; Bo Liu; Chun-Yu Chen; Burcin Uygungil; William Spoede; Jonathan A Bernstein; David P Huston; Yong-Jun Liu Journal: J Exp Med Date: 2010-10-04 Impact factor: 14.307
Authors: Laura McKinley; John F Alcorn; Alanna Peterson; Rachel B Dupont; Shernaaz Kapadia; Alison Logar; Adam Henry; Charles G Irvin; Jon D Piganelli; Anuradha Ray; Jay K Kolls Journal: J Immunol Date: 2008-09-15 Impact factor: 5.422
Authors: Tania Maes; Sharen Provoost; Ellen A Lanckacker; Didier D Cataldo; Jeroen A J Vanoirbeek; Benoit Nemery; Kurt G Tournoy; Guy F Joos Journal: Respir Res Date: 2010-01-21
Authors: Jane E Clougherty; Jonathan I Levy; Laura D Kubzansky; P Barry Ryan; Shakira Franco Suglia; Marina Jacobson Canner; Rosalind J Wright Journal: Environ Health Perspect Date: 2007-08 Impact factor: 9.031
Authors: Marjannie Eloi Akintunde; Melissa Rose; Paula Krakowiak; Luke Heuer; Paul Ashwood; Robin Hansen; Irva Hertz-Picciotto; Judy Van de Water Journal: J Neuroimmunol Date: 2015-07-11 Impact factor: 3.478
Authors: Hari K Somineni; Xue Zhang; Jocelyn M Biagini Myers; Melinda Butsch Kovacic; Ashley Ulm; Noelle Jurcak; Patrick H Ryan; Gurjit K Khurana Hershey; Hong Ji Journal: J Allergy Clin Immunol Date: 2015-12-10 Impact factor: 10.793
Authors: Jaclyn W McAlees; Theresa Baker; Davinder Kaur; Christopher McKnight; Andrew Lindsley; Richard T Strait; Xue Zhang; Jocelyn M Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich Journal: Allergy Date: 2019-07-02 Impact factor: 13.146
Authors: Eric B Brandt; Jocelyn M Biagini Myers; Patrick H Ryan; Gurjit K Khurana Hershey Journal: Curr Opin Pediatr Date: 2015-12 Impact factor: 2.856
Authors: Naina Gour; Kuladeep Sudini; Syed Muaz Khalil; Ana M Rule; Peter Lees; Edward Gabrielson; John D Groopman; Stephane Lajoie; Anju Singh Journal: Environ Res Date: 2017-11-24 Impact factor: 6.498
Authors: Chang Xiao; Jocelyn M Biagini Myers; Hong Ji; Kelly Metz; Lisa J Martin; Mark Lindsey; Hua He; Racheal Powers; Ashley Ulm; Brandy Ruff; Mark B Ericksen; Hari K Somineni; Jeffrey Simmons; Richard T Strait; Carolyn M Kercsmar; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2015-04-21 Impact factor: 10.793